What is Ubicept worth?
$43.0Mlast known valuation
Ubicept last raised $4.6M in its Seed Round (Jun 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for Ubicept
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2025 | Seed Round | $4.6M | ▮ | ▮ |
| May 2023 | Early Stage VC | $7.8M | ▮ | ▮ |
How Ubicept's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Ubicept, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Ubicept worth?
- Ubicept's last known valuation is $43.0M.
- How much has Ubicept raised?
- Ubicept has raised $12.7M in total funding across 2 recorded rounds.
- When did Ubicept last raise?
- Ubicept last raised in Jun 2025 (Seed Round), raising $4.6M.